[Physostigmine reversal of central anticholinergic syndrome induced by midazolam/fentanyl, benzoctamine/buprenorphine and etomidate/carticaine or by atropine/promethazine/pethidine for premedication? (author's transl)].
Five cases of post narcotic delirium, somnolence or coma are interpreted as central anticholinergic syndromes as they were reversed by physostigmine. There is to date no information whether the drug combinations midazolam/fentanyl, benzoctamine/buprenorphine and etomidate/carticaine may act as central anticholinergic agents.
D000328:Adult; D000368:Aged; D000873:Anthracenes / Q000009:adverse effects; D001285:Atropine / Q000009:adverse effects; D001569:Benzodiazepines / Q000009:adverse effects; D002047:Buprenorphine / Q000009:adverse effects; D002355:Carticaine / Q000009:adverse effects; D003128:Coma / Q000188:drug therapy*; D003693:Delirium / Q000188:drug therapy*; D005045:Etomidate / Q000009:adverse effects; D005283:Fentanyl / Q000009:adverse effects; D006801:Humans; D008297:Male; D008614:Meperidine / Q000009:adverse effects; D008874:Midazolam; D010276:Parasympatholytics / Q000009:adverse effects*; D010830:Physostigmine / Q000627:therapeutic use*; D011229:Preanesthetic Medication / Q000009:adverse effects*; D011398:Promethazine / Q000009:adverse effects
D000873:Anthracenes; D010276:Parasympatholytics; D001569:Benzodiazepines; D002047:Buprenorphine; C100247:benzoctamine; D001285:Atropine; D008614:Meperidine; D010830:Physostigmine; D002355:Carticaine; D011398:Promethazine; D008874:Midazolam; D005283:Fentanyl; D005045:Etomidate
Zentral-anticholinerges Syndrom induziert durch Midazolam/Fentanyl, Benzoctamin/Buprenorphin und Etomidat/Carticain oder durch Praemedikation mit Atropin/Promethazin/Pethidin?